Distinct Genetic Alterations in Colorectal Cancer

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2010 Feb 4

PMID 20126641

Citations 69

Authors

Hassan Ashktorab

Alejandro A Schaffer

Mohammad Daremipouran

Duane T Smoot

Edward Lee

Hassan Brim

Affiliations

Soon will be listed here.

Abstract

Background: Colon cancer (CRC) development often includes chromosomal instability (CIN) leading to amplifications and deletions of large DNA segments. Epidemiological, clinical, and cytogenetic studies showed that there are considerable differences between CRC tumors from African Americans (AAs) and Caucasian patients. In this study, we determined genomic copy number aberrations in sporadic CRC tumors from AAs, in order to investigate possible explanations for the observed disparities.

Methodology/principal Findings: We applied genome-wide array comparative genome hybridization (aCGH) using a 105k chip to identify copy number aberrations in samples from 15 AAs. In addition, we did a population comparative analysis with aCGH data in Caucasians as well as with a widely publicized list of colon cancer genes (CAN genes). There was an average of 20 aberrations per patient with more amplifications than deletions. Analysis of DNA copy number of frequently altered chromosomes revealed that deletions occurred primarily in chromosomes 4, 8 and 18. Chromosomal duplications occurred in more than 50% of cases on chromosomes 7, 8, 13, 20 and X. The CIN profile showed some differences when compared to Caucasian alterations.

Conclusions/significance: Chromosome X amplification in male patients and chromosomes 4, 8 and 18 deletions were prominent aberrations in AAs. Some CAN genes were altered at high frequencies in AAs with EXOC4, EPHB6, GNAS, MLL3 and TBX22 as the most frequently deleted genes and HAPLN1, ADAM29, SMAD2 and SMAD4 as the most frequently amplified genes. The observed CIN may play a distinctive role in CRC in AAs.

Citing Articles

Data-Driven Identification of Early Cancer-Associated Genes via Penalized Trans-Dimensional Hidden Markov Models.

Hajebi Khaniki S, Shokoohi F Biomolecules. 2025; 15(2).

PMID: 40001597 PMC: 11853217. DOI: 10.3390/biom15020294.

A Hyaluronan and Proteoglycan Link Protein 1 Matrikine: Role of Matrix Metalloproteinase 2 in Multiple Myeloma NF-κB Activation and Drug Resistance.

Mark C, Warrick J, Callander N, Hematti P, Miyamoto S Mol Cancer Res. 2022; 20(9):1456-1466.

PMID: 35604822 PMC: 9444915. DOI: 10.1158/1541-7786.MCR-21-0941.

MiR-509-3p is oncogenic, targets the tumor suppressor PHLPP2, and functions as a novel tumor adjacent normal tissue based prognostic biomarker in colorectal cancer.

Iyer D, Foo D, Lo O, Wan T, Li X, Sin R BMC Cancer. 2022; 22(1):351.

PMID: 35361144 PMC: 8969217. DOI: 10.1186/s12885-021-09075-x.

Loss of Hyaluronan and Proteoglycan Link Protein-1 Induces Tumorigenesis in Colorectal Cancer.

Wang Y, Xu X, Marshall J, Gong M, Zhao Y, Dua K Front Oncol. 2021; 11:754240.

PMID: 34966673 PMC: 8710468. DOI: 10.3389/fonc.2021.754240.

Deciphering Promoter Hypermethylation of Genes Encoding for RASSF/Hippo Pathway Reveals the Poor Prognostic Factor of RASSF2 Gene Silencing in Colon Cancers.

Riffet M, Eid Y, Faisant M, Fohlen A, Menahem B, Alves A Cancers (Basel). 2021; 13(23).

PMID: 34885067 PMC: 8656858. DOI: 10.3390/cancers13235957.

References

Edwards D, Handsley M, Pennington C . The ADAM metalloproteinases. Mol Aspects Med. 2008; 29(5):258-89. PMC: 7112278. DOI: 10.1016/j.mam.2008.08.001. View

Fox B, Kandpal R . EphB6 receptor significantly alters invasiveness and other phenotypic characteristics of human breast carcinoma cells. Oncogene. 2009; 28(14):1706-13. DOI: 10.1038/onc.2009.18. View

Georgiades I, Curtis L, Morris R, Bird C, Wyllie A . Heterogeneity studies identify a subset of sporadic colorectal cancers without evidence for chromosomal or microsatellite instability. Oncogene. 2000; 18(56):7933-40. DOI: 10.1038/sj.onc.1203368. View

James M, Skaar T, Lee R, Macpherson A, Zwiebel J, Ahluwalia B . Constitutive expression of the steroid sulfatase gene supports the growth of MCF-7 human breast cancer cells in vitro and in vivo. Endocrinology. 2001; 142(4):1497-505. DOI: 10.1210/endo.142.4.8091. View

Naishiro Y, Yamada T, Idogawa M, Honda K, Takada M, Kondo T . Morphological and transcriptional responses of untransformed intestinal epithelial cells to an oncogenic beta-catenin protein. Oncogene. 2005; 24(19):3141-53. DOI: 10.1038/sj.onc.1208517. View

Goel A, Arnold C, Niedzwiecki D, Chang D, Ricciardiello L, Carethers J . Characterization of sporadic colon cancer by patterns of genomic instability. Cancer Res. 2003; 63(7):1608-14. View

Unotoro J, Kamiyama H, Ishido Y, Yaginuma Y, Kasamaki S, Sakamoto K . Analysis of the relationship between sex and chromosomal aberrations in colorectal cancer by comparative genomic hybridization. J Int Med Res. 2006; 34(4):397-405. DOI: 10.1177/147323000603400409. View

Clarke D, Brown M, Erickson R, Shi Y, Liu X . Transforming growth factor beta depletion is the primary determinant of Smad signaling kinetics. Mol Cell Biol. 2009; 29(9):2443-55. PMC: 2668365. DOI: 10.1128/MCB.01443-08. View

Weizman N, Shiloh Y, Barzilai A . Contribution of the Atm protein to maintaining cellular homeostasis evidenced by continuous activation of the AP-1 pathway in Atm-deficient brains. J Biol Chem. 2002; 278(9):6741-7. DOI: 10.1074/jbc.M211168200. View

10.

Sakurai-Yageta M, Recchi C, Le Dez G, Sibarita J, Daviet L, Camonis J . The interaction of IQGAP1 with the exocyst complex is required for tumor cell invasion downstream of Cdc42 and RhoA. J Cell Biol. 2008; 181(6):985-98. PMC: 2426946. DOI: 10.1083/jcb.200709076. View

11.

Lassmann S, Weis R, Makowiec F, Roth J, Danciu M, Hopt U . Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas. J Mol Med (Berl). 2006; 85(3):293-304. DOI: 10.1007/s00109-006-0126-5. View

12.

Tsafrir D, Bacolod M, Selvanayagam Z, Tsafrir I, Shia J, Zeng Z . Relationship of gene expression and chromosomal abnormalities in colorectal cancer. Cancer Res. 2006; 66(4):2129-37. DOI: 10.1158/0008-5472.CAN-05-2569. View

13.

Muleris M, Dutrillaux A, Olschwang S, Salmon R, Dutrillaux B . Predominance of normal karyotype in colorectal tumors from hereditary non-polyposis colorectal cancer patients. Genes Chromosomes Cancer. 1995; 14(3):223-6. DOI: 10.1002/gcc.2870140312. View

14.

Camps J, Armengol G, Rey J, Lozano J, Vauhkonen H, Prat E . Genome-wide differences between microsatellite stable and unstable colorectal tumors. Carcinogenesis. 2005; 27(3):419-28. DOI: 10.1093/carcin/bgi244. View

15.

Laramie J, Wilk J, Williamson S, Nagle M, Latourelle J, Tobin J . Polymorphisms near EXOC4 and LRGUK on chromosome 7q32 are associated with Type 2 Diabetes and fasting glucose; the NHLBI Family Heart Study. BMC Med Genet. 2008; 9:46. PMC: 2409301. DOI: 10.1186/1471-2350-9-46. View

16.

Lehnerdt G, Franz P, Winterhoff S, Bankfalvi A, Grehl S, Lang S . The GNAS1 T393C polymorphism predicts survival in patients with advanced squamous cell carcinoma of the larynx. Laryngoscope. 2008; 118(12):2172-6. DOI: 10.1097/MLG.0b013e318185793ds. View

17.

Sjoblom T, Jones S, Wood L, Parsons D, Lin J, Barber T . The consensus coding sequences of human breast and colorectal cancers. Science. 2006; 314(5797):268-74. DOI: 10.1126/science.1133427. View

18.

Zuo T, Wang L, Morrison C, Chang X, Zhang H, Li W . FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene. Cell. 2007; 129(7):1275-86. PMC: 1974845. DOI: 10.1016/j.cell.2007.04.034. View

19.

Bardi G, Sukhikh T, Pandis N, Fenger C, Kronborg O, Heim S . Karyotypic characterization of colorectal adenocarcinomas. Genes Chromosomes Cancer. 1995; 12(2):97-109. DOI: 10.1002/gcc.2870120204. View

20.

Fearon E, Vogelstein B . A genetic model for colorectal tumorigenesis. Cell. 1990; 61(5):759-67. DOI: 10.1016/0092-8674(90)90186-i. View